WENTWORTH JARRETT: Open Payments
NPI 1104836972 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,849 in 63 payments from 15 companies in 2025. Trend: 2023 $1,252 · 2024 $1,780 · 2025 $1,849
Food & beverage: $1,849
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $386 |
| AstraZeneca Pharmaceuticals LP | 12 | $380 |
| Corcept Therapeutics | 7 | $199 |
| Lilly USA, LLC | 8 | $168 |
| Astellas Pharma US Inc | 4 | $136 |
| Amgen Inc. | 6 | $129 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Abbott Laboratories | 4 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
Products named: Ozempic, FARXIGA, JARDIANCE, Korlym, Veozah, FREESTYLE LIBRE 3, Kerendia, OTEZLA.
Industry payments across FL — which companies pay providers there.
